These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 15921027)
1. Cefazolin concentrations in serum during cardiopulmonary bypass surgery. Miglioli PA; Merlo F; Calabrò GB; Allerberger F; Fille M Drugs Exp Clin Res; 2005; 31(1):29-33. PubMed ID: 15921027 [TBL] [Abstract][Full Text] [Related]
2. Plasma cefazolin levels during cardiovascular surgery: effects of cardiopulmonary bypass and profound hypothermic circulatory arrest. Caffarelli AD; Holden JP; Baron EJ; Lemmens HJ; D'Souza H; Yau V; Olcott C; Reitz BA; Miller DC; van der Starre PJ J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1338-43. PubMed ID: 16733167 [TBL] [Abstract][Full Text] [Related]
3. Effects of cardio-pulmonary bypass on vancomycin plasma concentration decay. Miglioli PA; Merlo F; Grabocka E; Padrini R Pharmacol Res; 1998 Oct; 38(4):275-8. PubMed ID: 9774490 [TBL] [Abstract][Full Text] [Related]
4. Effects of cardiopulmonary bypass on teicoplanin serum disposition. Miglioli PA; Merlo F; Campanile F; Padrini R Int J Clin Pharmacol Res; 1995; 15(1):23-5. PubMed ID: 7490171 [TBL] [Abstract][Full Text] [Related]
5. Amikacin administration in open heart surgery. Oto O; Tunçok Y; Apaydin S; Açikel U; Güven H Panminerva Med; 1995 Jun; 37(2):65-7. PubMed ID: 8637771 [TBL] [Abstract][Full Text] [Related]
6. Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery. Fellinger EK; Leavitt BJ; Hebert JC Ann Thorac Surg; 2002 Oct; 74(4):1187-90. PubMed ID: 12400766 [TBL] [Abstract][Full Text] [Related]
7. Effects of cardiopulmonary bypass on the disposition of cefazolin in patients undergoing cardiothoracic surgery. Asada M; Nagata M; Mizuno T; Uchida T; Kurashima N; Takahashi H; Makita K; Arai H; Echizen H; Yasuhara M Pharmacol Res Perspect; 2018 Dec; 6(6):e00440. PubMed ID: 30410768 [TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle and plasma concentrations of cefazolin during cardiac surgery in infants. Himebauch AS; Nicolson SC; Sisko M; Moorthy G; Fuller S; Gaynor JW; Zuppa AF; Fox E; Kilbaugh TJ J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2634-41. PubMed ID: 25131168 [TBL] [Abstract][Full Text] [Related]
9. Proteolytic and cytokine balance abnormalities in children with congenital heart disease undergoing cardiac surgery with cardiopulmonary bypass. Paśnik J; Moll J; Cywińska-Bernas A; Moll J; Sysa A; Zeman K Kardiol Pol; 2007 Oct; 65(10):1208-14; discussion 1215. PubMed ID: 17979049 [TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery. De Cock PA; Mulla H; Desmet S; De Somer F; McWhinney BC; Ungerer JP; Moerman A; Commeyne S; Vande Walle J; Francois K; Van Hasselt JG; De Paepe P J Antimicrob Chemother; 2017 Mar; 72(3):791-800. PubMed ID: 27999040 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic prophylaxis with cefazolin and gentamicin in cardiac surgery for children less than ten kilograms. Haessler D; Reverdy ME; Neidecker J; Brûlé P; Ninet J; Lehot JJ J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):221-5. PubMed ID: 12698406 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of cefazolin delivery via the cardiopulmonary bypass circuit priming solution in infants and children. Cies JJ; Moore WS; Parker J; Stevens R; Al-Qaqaa Y; Enache A; Chopra A J Antimicrob Chemother; 2019 May; 74(5):1342-1347. PubMed ID: 30689931 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery. Asada M; Nagata M; Mizuno T; Uchida T; Takahashi H; Makita K; Arai H; Kijima S; Echizen H; Yasuhara M Eur J Clin Pharmacol; 2021 May; 77(5):735-745. PubMed ID: 33211137 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass. Calic D; Ariano RE; Arora RC; Grocott HP; Lakowski TM; Lillico R; Zelenitsky SA J Antimicrob Chemother; 2018 Mar; 73(3):768-771. PubMed ID: 29237016 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery. Lanckohr C; Horn D; Voeller S; Hempel G; Fobker M; Welp H; Koeck R; Ellger B J Thorac Cardiovasc Surg; 2016 Aug; 152(2):603-10. PubMed ID: 27209020 [TBL] [Abstract][Full Text] [Related]
16. [Effects of cardiopulmonary bypass on plasma pentraxin-3 level and the balance of Th1/Th2 function in children with congenital heart malformations]. Wang SY; Li TY; Zheng YQ Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(15):1024-7. PubMed ID: 19595250 [TBL] [Abstract][Full Text] [Related]
17. A pilot study to determine the feasibility of continuous cefazolin infusion. Waltrip T; Lewis R; Young V; Farmer M; Clayton S; Myers S; Gray LA; Galandiuk S Surg Infect (Larchmt); 2002; 3(1):5-9. PubMed ID: 12593694 [TBL] [Abstract][Full Text] [Related]
18. A pilot and feasibility study of the plasma and tissue pharmacokinetics of cefazolin in an immature porcine model of pediatric cardiac surgery. Kilbaugh TJ; Himebauch AS; Zaoutis T; Jobes D; Greeley WJ; Nicolson SC; Zuppa AF Paediatr Anaesth; 2015 Nov; 25(11):1111-9. PubMed ID: 26372607 [TBL] [Abstract][Full Text] [Related]
19. [Effect of hydroxyethyl starch 130/0.4 on S100B protein level and cerebral oxygen metabolism in open cardiac surgery under cardiopulmonary bypass]. Pi ZB; Tan GX; Wang JL Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1908-11. PubMed ID: 17923015 [TBL] [Abstract][Full Text] [Related]
20. Serum S100B levels in patients after cardiac surgery: possible sources of contamination. Babin-Ebell J; Roth P; Reese J; Bechtel M; Mortasawi A Thorac Cardiovasc Surg; 2007 Apr; 55(3):168-72. PubMed ID: 17410502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]